- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Non-Hodgkin's Lymphoma Incidence
In epidemiology, "incidence rate" is a measure of how many people within a given population will develop a disease or other condition during a specified period of time. It is, essentially, a measurement of risk.
The National Cancer Institute estimates that 65,980 new cases of Non-Hodgkin's Lymphoma will be diagnosed in 2009. This represents 89% of all lymphomas, and 4% of all cancers diagnosed. It is the seventh most common cancer in the United States.
According to the Leukemia and Lymphoma Society:
- The chance of developing Non-Hodgkin's Lymphoma during your lifetime is 1 in 50, or 2%. However, this percentage increases if you have one or more risk factors for the disease.
- NHL is more prevalent in males than females–55% of lymphoma diagnoses are for male patients
- Of those diagnosed with the disease, 95% are adults and 5% are children
- It is more prevalent in patients over the age of 60
- The average age at diagnosis is 65
- Due to aging of the "baby boom" population, the incidence of NHL is expected to rise in the coming years
Lymphoma is a well-researched subject and many statistics are published annually. For the most up-to-date and complete statistical information on lymphoma, please see the resources listed at the bottom of the page.